Tag Archives: Antibiotics

Antibiotics Discovery: Time for a ‘Manhattan Project’

by Susan Crowley The innovative pharmaceutical industry is under attack from critics around the world for failing to develop new antibiotics to treat emerging infections. The charge has been furthered by statements from World Health Organization (WHO) director Margaret Chan. In 2012, she warned that bacteria were starting to become so resistant to common antibiotics […]
Posted in Corporate Responsibility, Global, Guest Blog, healthcare, IP, leadership, Manufacturing, Market Access, R&D, Strategy | Also tagged , , , , , , | 4 Comments

Unlikely European Allies Target Superbugs

The annual worldwide antibiotic awareness event—celebrated in Europe on November 15—generated some alarming statistics, some reassuring statements from official sources, and some expressions of urgency from drug developers. But it was perhaps most compellingly marked by a plangent call for better medicines from an unusual source. First, the statistics. Superbugs are on the way to […]
Posted in Europe, Events, Guest Blog, healthcare | Also tagged , , | Leave a comment

Refilling the Antibiotic Pipeline: How to Lead the Horse to Water?

Last week, the United States Center for Disease Control (CDC) and Britain’s Chief Medical Officer issued separate warnings about the urgent problem of antibiotic resistance in infectious diseases. Given industry’s general lack of interest in developing new antibiotics to address this problem, the warnings indicate that a discussion is needed around which incentives and regulatory […]
Posted in FDA, Global, Market Access, pricing, R&D, Regulatory, Safety, Strategy | Also tagged , , , | 1 Comment
  • Categories

  • Meta